Clinical trial
Mavacamten for Improving Cardiac Function and Clinical Outcomes in Adult Patients With Obstructive Hypertrophic Cardiomyopathy: A Retrospective Cohort Study
NCT07529938 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences, Fuwai Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mavacamten for Improving Cardiac Function and Clinical Outcomes in Adult Patients With Obstructive Hypertrophic Cardiomyopathy: A Retrospective Cohort Study
- Lead sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2024
- Completion date
- June 30, 2025
- Enrollment
- 222 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypertrophic cardiomyopathy (hcm), obstructive hypertrophic cardiomyopathy (ohcm)